Review

. 2019 Dec:172:104611.

doi: 10.1016/j.antiviral.2019.104611. Epub 2019 Sep 20.

GloPID-R report on chikungunya, o'nyong-nyong and Mayaro virus, part 2: Epidemiological distribution of o'nyong-nyong virus

Collaborators, Affiliations

Collaborators

GloPID-R chikungunya, o'nyong-nyong and Mayaro virus Working Group:
S Boyer¹³, P Brasil¹⁴, M Busch¹⁵, M S Diamond¹⁶, M A Drebot¹⁷, A Kohl¹⁸, M Lecuit¹⁹, R Lourenço-de-Oliveira²⁰, J Neyts²¹, Ng Lfp²², G S Ribeiro²³, M Rios²⁴, A J Rodriguez-Morales²⁵, M G Rosa-Freitas²⁰, G Simmons²⁶, A M Siqueira¹⁴, A Vega Rua²⁷

Affiliations

¹ Unité des Virus Émergents (UVE: Aix-Marseille Univ-IRD 190-Inserm 1207-IHU Méditerranée Infection), Marseille, France; EA7310, Laboratoire de Virologie, Université de Corse-Inserm, Corte, France. Electronic address: laura.pezzi3@studio.unibo.it.
² Department of Pediatrics, Division of Infectious Diseases, Stanford University School of Medicine, Stanford, USA.
³ Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands; Department Viroscience, Erasmus University Medical Center, Rotterdam, the Netherlands.
⁴ Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, And Berlin Institute of Health, Institute of Virology, 10117, Berlin, Germany; German Centre for Infection Research (DZIF), Germany.
⁵ Department of Pathology, Institute of Human Infection and Immunity, University of Texas Medical Branch, Galveston, USA.
⁶ Unité D'Entomologie Médicale, Institut Pasteur de Dakar, Dakar, Senegal.
⁷ Laveran Military Teaching Hospital, Marseille, France.
⁸ Section Clinical Tropical Medicine, Department of Infectious Diseases, Heidelberg University Hospital, Heidelberg, Germany.
⁹ Établissement Français Du Sang Alpes Méditerranée, Marseille, France.
¹⁰ Department of Virology, Institut Pasteur, Arboviruses and Insect Vectors Unit, Paris, France.
¹¹ Institute for Human Infections and Immunity and Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, USA.
¹² Unité des Virus Émergents (UVE: Aix-Marseille Univ-IRD 190-Inserm 1207-IHU Méditerranée Infection), Marseille, France.
¹³ Medical Entomology Platform, Institut Pasteur Du Cambodge, Phnom Penh, Cambodia.
¹⁴ Instituto Nacional de Infectologia Evandro Chagas - Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
¹⁵ Blood Systems Research Institute, San Francisco, and Department of Laboratory Medicine, University of California, San Francisco, USA.
¹⁶ Department of Medicine, and the Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs, Washington University School of Medicine, St. Louis, USA; Department of Molecular Microbiology, And the Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs, Washington University School of Medicine, St. Louis, USA; Department of Pathology and Immunology, And the Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs, Washington University School of Medicine, St. Louis, USA.
¹⁷ Zoonotic Diseases and Special Pathogens, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Canada.
¹⁸ MRC-University of Glasgow Centre for Virus Research, Glasgow, UK.
¹⁹ Institut Pasteur, Biology of Infection Unit, Inserm U1117, Paris Descartes University, Departement of Infectious Diseases and Tropical Medicine, Necker-Enfants Malades University Hospital, APHP, IHU Imagine, Paris, France.
²⁰ Instituto Oswaldo Cruz-Fiocruz, Laboratório de Mosquitos Transmissores de Hematozoários, Rio de Janeiro, Brazil.
²¹ KU Leuven, Department of Microbiology and Immunology, Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, Leuven, Belgium.
²² Singapore Immunology Network, Agency for Science, Technology and Research (A*STAR), Singapore.
²³ Gonçalo Moniz Institute, Oswaldo Cruz Foundation, And Federal University of Bahia, Salvador, Brazil.
²⁴ Division of Emerging and Transfusion Transmitted Diseases, Laboratory of Emerging Pathogens, Office of Blood Research and Review, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, USA.
²⁵ Public Health and Infection Research Group, Faculty of Health Sciences, Universidad Tecnologica de Pereira, Pereira, Colombia.
²⁶ Blood Systems Research Institute, San Francisco, USA, And Department of Pathology and Laboratory Medicine, University of California, San Francisco, San Francisco, USA.
²⁷ Laboratory of Vector Control Research, Environment and Health Unit, Institut Pasteur de La Guadeloupe, Guadeloupe.

PMID: 31545982
DOI: 10.1016/j.antiviral.2019.104611

Free article

Review

GloPID-R report on chikungunya, o'nyong-nyong and Mayaro virus, part 2: Epidemiological distribution of o'nyong-nyong virus

L Pezzi et al. Antiviral Res. 2019 Dec.

Free article

. 2019 Dec:172:104611.

doi: 10.1016/j.antiviral.2019.104611. Epub 2019 Sep 20.

Authors

Collaborators

GloPID-R chikungunya, o'nyong-nyong and Mayaro virus Working Group:
S Boyer¹³, P Brasil¹⁴, M Busch¹⁵, M S Diamond¹⁶, M A Drebot¹⁷, A Kohl¹⁸, M Lecuit¹⁹, R Lourenço-de-Oliveira²⁰, J Neyts²¹, Ng Lfp²², G S Ribeiro²³, M Rios²⁴, A J Rodriguez-Morales²⁵, M G Rosa-Freitas²⁰, G Simmons²⁶, A M Siqueira¹⁴, A Vega Rua²⁷

Affiliations

¹ Unité des Virus Émergents (UVE: Aix-Marseille Univ-IRD 190-Inserm 1207-IHU Méditerranée Infection), Marseille, France; EA7310, Laboratoire de Virologie, Université de Corse-Inserm, Corte, France. Electronic address: laura.pezzi3@studio.unibo.it.
² Department of Pediatrics, Division of Infectious Diseases, Stanford University School of Medicine, Stanford, USA.
³ Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands; Department Viroscience, Erasmus University Medical Center, Rotterdam, the Netherlands.
⁴ Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, And Berlin Institute of Health, Institute of Virology, 10117, Berlin, Germany; German Centre for Infection Research (DZIF), Germany.
⁵ Department of Pathology, Institute of Human Infection and Immunity, University of Texas Medical Branch, Galveston, USA.
⁶ Unité D'Entomologie Médicale, Institut Pasteur de Dakar, Dakar, Senegal.
⁷ Laveran Military Teaching Hospital, Marseille, France.
⁸ Section Clinical Tropical Medicine, Department of Infectious Diseases, Heidelberg University Hospital, Heidelberg, Germany.
⁹ Établissement Français Du Sang Alpes Méditerranée, Marseille, France.
¹⁰ Department of Virology, Institut Pasteur, Arboviruses and Insect Vectors Unit, Paris, France.
¹¹ Institute for Human Infections and Immunity and Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, USA.
¹² Unité des Virus Émergents (UVE: Aix-Marseille Univ-IRD 190-Inserm 1207-IHU Méditerranée Infection), Marseille, France.
¹³ Medical Entomology Platform, Institut Pasteur Du Cambodge, Phnom Penh, Cambodia.
¹⁴ Instituto Nacional de Infectologia Evandro Chagas - Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
¹⁵ Blood Systems Research Institute, San Francisco, and Department of Laboratory Medicine, University of California, San Francisco, USA.
¹⁶ Department of Medicine, and the Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs, Washington University School of Medicine, St. Louis, USA; Department of Molecular Microbiology, And the Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs, Washington University School of Medicine, St. Louis, USA; Department of Pathology and Immunology, And the Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs, Washington University School of Medicine, St. Louis, USA.
¹⁷ Zoonotic Diseases and Special Pathogens, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Canada.
¹⁸ MRC-University of Glasgow Centre for Virus Research, Glasgow, UK.
¹⁹ Institut Pasteur, Biology of Infection Unit, Inserm U1117, Paris Descartes University, Departement of Infectious Diseases and Tropical Medicine, Necker-Enfants Malades University Hospital, APHP, IHU Imagine, Paris, France.
²⁰ Instituto Oswaldo Cruz-Fiocruz, Laboratório de Mosquitos Transmissores de Hematozoários, Rio de Janeiro, Brazil.
²¹ KU Leuven, Department of Microbiology and Immunology, Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, Leuven, Belgium.
²² Singapore Immunology Network, Agency for Science, Technology and Research (A*STAR), Singapore.
²³ Gonçalo Moniz Institute, Oswaldo Cruz Foundation, And Federal University of Bahia, Salvador, Brazil.
²⁴ Division of Emerging and Transfusion Transmitted Diseases, Laboratory of Emerging Pathogens, Office of Blood Research and Review, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, USA.
²⁵ Public Health and Infection Research Group, Faculty of Health Sciences, Universidad Tecnologica de Pereira, Pereira, Colombia.
²⁶ Blood Systems Research Institute, San Francisco, USA, And Department of Pathology and Laboratory Medicine, University of California, San Francisco, San Francisco, USA.
²⁷ Laboratory of Vector Control Research, Environment and Health Unit, Institut Pasteur de La Guadeloupe, Guadeloupe.

PMID: 31545982
DOI: 10.1016/j.antiviral.2019.104611

Abstract

The GloPID-R (Global Research Collaboration for Infectious Disease Preparedness) chikungunya (CHIKV), o'nyong-nyong (ONNV) and Mayaro virus (MAYV) Working Group has been established to identify gaps of knowledge about the natural history, epidemiology and medical management of infection by these viruses, and to provide adapted recommendations for future investigations. Here, we present a report dedicated to ONNV epidemiological distribution. Two large-scale ONNV outbreaks have been identified in Africa in the last 60 years, interspersed with sporadic serosurveys and case reports of returning travelers. The assessment of the real scale of ONNV circulation in Africa remains a difficult task and surveillance studies are necessary to fill this gap. The identification of ONNV etiology is made complicated by the absence of multiplex tools in co-circulation areas and that of reference standards, as well as the high cross-reactivity with related pathogens observed in serological tests, in particular with CHIKV. This is a specific obstacle for seroprevalence studies, that necessitate an improvement of serological tools to provide robust results. The scarcity of existent genetic data currently limits molecular epidemiology studies. ONNV epidemiology would also benefit from reinforced entomological and environmental surveillance. Finally, the natural history of the disease deserves to be further investigated, with a specific attention paid to long-term complications. Considering our incomplete knowledge on ONNV distribution, GloPID-R CHIKV, ONNV and MAYV experts recommend that a major effort should be done to fill existing gaps.

PubMed Disclaimer

Cited by

Pathogenicity and virulence of O'nyong-nyong virus: A less studied Togaviridae with pandemic potential.
Tong Jia Ming S, Tan Yi Jun K, Carissimo G. Tong Jia Ming S, et al. Virulence. 2024 Dec;15(1):2355201. doi: 10.1080/21505594.2024.2355201. Epub 2024 May 26. Virulence. 2024. PMID: 38797948 Free PMC article. Review.
Strategic considerations on developing a CHIKV vaccine and ensuring equitable access for countries in need.
Cherian N, Bettis A, Deol A, Kumar A, Di Fabio JL, Chaudhari A, Yimer S, Fahim R, Endy T. Cherian N, et al. NPJ Vaccines. 2023 Aug 18;8(1):123. doi: 10.1038/s41541-023-00722-x. NPJ Vaccines. 2023. PMID: 37596253 Free PMC article. Review.
Knockdown resistance allele L1014F introduced by CRISPR/Cas9 is not associated with altered vector competence of Anopheles gambiae for o'nyong nyong virus.
Kay GA, Patterson EI, Hughes GL, Lord JS, Reimer LJ. Kay GA, et al. PLoS One. 2023 Aug 10;18(8):e0288994. doi: 10.1371/journal.pone.0288994. eCollection 2023. PLoS One. 2023. PMID: 37561739 Free PMC article.
Seroprevalence of Alphaviruses (Togaviridae) among Urban Population in Nouakchott, Mauritania, West Africa.
Abdoullah B, Durand GA, Basco LK, El Bara A, Bollahi MA, Bosio L, Geulen M, Briolant S, Boukhary AOMS. Abdoullah B, et al. Viruses. 2023 Jul 20;15(7):1588. doi: 10.3390/v15071588. Viruses. 2023. PMID: 37515274 Free PMC article.
Vector competence of Anopheles stephensi for O'nyong-nyong virus: a risk for global virus spread.
Mutsaers M, Engdahl CS, Wilkman L, Ahlm C, Evander M, Lwande OW. Mutsaers M, et al. Parasit Vectors. 2023 Apr 17;16(1):133. doi: 10.1186/s13071-023-05725-0. Parasit Vectors. 2023. PMID: 37069603 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Ovid Technologies, Inc.
Medical
- Genetic Alliance
Miscellaneous
- NCI CPTAC Assay Portal

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

GloPID-R report on chikungunya, o'nyong-nyong and Mayaro virus, part 2: Epidemiological distribution of o'nyong-nyong virus

Collaborators

Affiliations

GloPID-R report on chikungunya, o'nyong-nyong and Mayaro virus, part 2: Epidemiological distribution of o'nyong-nyong virus

Authors

Collaborators

Affiliations

Abstract

Similar articles

Cited by

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Miscellaneous

Abstract

Similar articles

Cited by

Publication types

MeSH terms

Substances

Related information

LinkOut - more resources

Full Text Sources

Medical

Miscellaneous